Skip to main content
. 2013 Oct 7;7:1025–1039. doi: 10.2147/PPA.S47785

Table 1.

Questionnaire data means and comparisons between pre-intervention and post-intervention times

VI Pre-intervention
V2 Immediately post-intervention
V3 3 months post-intervention
Overall P-value VI × V2
VI × V3
V2 × V3
Mean 95% CI Mean 95% CI Mean 95% CI VI–V2 P-value VI–V3 P-value V2–V3 P-value
IPQ-R
 TL 18.2 (17.7–18.6) 23.9 (22.4–25.3) 24.2 (22.9–254) <0.0001 −5.7 <0.0001 −6.0 <0.0001 −0.3 0.8
 TC 13.2 (1 1.3–15.1) 10.3 (8.2–12.3) 10.0 (7.2–12.7) <0.0001 3.0 0.001 3.3 <0.0001 0.3 0.2
 C 14.5 (13.0–16.0) 16.4 (15.6–17.1) 16.7 (15.5–17.8) 0.003 −1.9 0.01 −2.2 0.01 −0.3 0.5
 PC 14.1 (I3.I–I5.I) 16.2 (15.4–16.9) 15.9 (15.1–16.7) 0.002 −2.1 0.003 −1.8 0.012 0.2 0.4
 TC 13.9 (13.2–14.6) 16.8 (15.7–17.8) 17.0 (15.8–18.2) <0.0001 −2.8 0.005 −3.1 <0.0001 −0.3 0.134
 IC 9.6 (8.7–10.5) 12.7 (12.0–13.4) 12.7 (11.8–13.5) <0.0001 −3.1 <0.0001 −3.1 <0.0001 0.1 0.8
 ET 13.5 (12.5–14.4) 17.5 (16.9–18.1) 16.8 (15.9–17.6) <0.0001 −4.1 <0.0001 −3.3 <0.0001 0.8 0.1
PEI 4.1 (2.6,5.5) 6.6 (4.9–8.3) 6.7 (4.9–8.5) 0.006 −2.6 0.008 −2.7 0.012 −0.1 0.4
BMQ
 NS 3.7 (3.3–4.1) 3.9 (3.5–4.2) 4.1 (3.8–4.4) 0.055 −0.2 0.3 −0.4 0.0174 −0.2 0.2
 SC 2.1 (1.8–2.4) 2.0 (1.7–2.2) 1.9 (1.6–2.2) 0.391 0.2 0.2 0.2 0.3 0.1 0.8
SFI2 41.6 (40.1–43.2) 39.2 (37.0–41.3) 40.7 (39.2–42.3) 0.167 2.4 0.2 0.9 0.8 −1.6 0.052
GAQ 10.1 (8.3–11.9) 14.1 (124–15.8) 13.5 (11.8–15.1) <0.0001 −4.0 <0.0001 −3.4 <0.0001 0.7 0.3

Notes:

Threshold for significance is 5%/2 = 0.025 due to multiple testing of pairwise comparisons;

Friedman’s nonparametric test used for overall P-value, and pairwise comparisons due to normality or sphericity being violated.

Abbreviations: CI, confidence interval; IPQ-R, Revised Illness Perception Questionnaire; TL, timeline; TC, timecycle; C, consequences; PC, personal control; TC, treatment control; IC, illness coherence; ET emotional trauma; PEI, Patient Enablement Instrument; BMQ, Beliefs about Medicine Questionnaire; NS, necessity subscale; CS, concerns subscale; SFI2, Short Form-12; GAQ, Glaucoma Adherence Questionnaire. Knowledge questions only (maximum score 19).